Clinical outcomes of primary intracranial malignant melanoma and metastatic intracranial malignant melanoma

According to our experience, PIMM is very aggressive malignant tumor. Its median survival was less than 1 year. We suggest that maximal safe resection plus adjuvant RT and CTX for intracranial malignant melanoma considering highly aggressive clinical course of this tumors.